Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandrakant Vallabhaji Gogri, a promoter of Aarti Pharmalabs Limited, has submitted a declaration to the exchanges under SEBI's Takeover Regulations. He confirmed that none of the Promoters, Promoter Group members, or Persons Acting in Concert (PACs) have created any encumbrance (such as pledging or hypothecation) on the company's shares during Financial Year 2024-25. The filing includes the list of 47 promoter and promoter group entities. This is a routine annual compliance filing required when no encumbrance has been created.
This is a neutral to mildly positive disclosure for shareholders. It confirms that the promoter group has not pledged any of their shares as collateral during FY2024-25, reducing concerns about forced selling or margin call risks. No material impact on the stock price is expected as this is a non-event confirmation.